MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • MDS Virtual Congress 2021

    Characterizing the temporal discrimination threshold in musician’s dystonia

    F. Borngräber, M. Hoffmann, T. Paulus, J. Junker, T. Bäumer, E. Altenmüller, A. Kühn, A. Schmidt (Berlin, Germany)

    Objective: To compare the temporal discrimination threshold (TDT) between musician's dystonia (MD) patients, healthy musicians and non-musician controls. Background: MD is a focal, task specific…
  • MDS Virtual Congress 2021

    The online MDS educational resources helped young neurologists maintain their training during the Covid-19 pandemic

    S. El-Jaafary, M. Fabbri, T. de Lariestra, M. Matarazzo, B. Bergmans, M. Carecchio, R. Rajan, N. Vijiaratnam, H. Tibar, B. Bloem (Cairo, Egypt)

    Objective: To analyse the impact of the COVID-19 pandemic on the young MDS members assessing their satisfaction with the MDS virtual educational tools. Background: The…
  • MDS Virtual Congress 2021

    Optimizing an Electronic Health Records (EHR)-based Algorithm for Parkinson’s Disease Case Ascertainment

    A. Duarte Folle, L. Uhr, F. Agosta, T. Chang, C. Baddley, B. Ritz, C. Tanner, A. Wu, A. Wilson (Los Angeles, USA)

    Objective: To develop an EHR-based algorithm to classify patients with PD into three levels of diagnostic certainty. Background: EHRs can be a rich source of…
  • MDS Virtual Congress 2021

    Emerging parkinsonism in the PREDICT-PD cohort after 6-years of follow-up

    C. Simonet, A. Gill, J. Bestwick, A. Lees, G. Giovannoni, A. Schrag, A. Noyce (London, United Kingdom)

    Objective: To determine how motor features emerge over time in individuals estimated to be at higher risk of Parkinson’s disease (PD), compared with lower risk…
  • MDS Virtual Congress 2021

    Acute functional movement disorder in a Lupus patient

    D. Rebolledo, J. Diestel, I. Reyes (Mexico City, Mexico)

    Objective: Movement disorders (MD) in autoimmune diseases are uncommon. However, the initial presentation required that the clinicians characterize the clinical phenomenology. Rheumatological patients' complexity required…
  • MDS Virtual Congress 2021

    Widespread loss of presynaptic terminal marker SV2A in early Huntington’s disease.

    A. Delva, L. Michiels, M. Koole, K. van Laere, W. Vandenberghe (Leuven, Belgium)

    Objective: To assess synaptic damage in early stages of Huntington’s disease (HD) in vivo. Background: Synaptic damage has long been suspected to play a major…
  • MDS Virtual Congress 2021

    Risk and timing of manifest Huntington’s disease in patients with reduced penetrance alleles

    E. Mcdonnell, Y. Wang, K. Marder (New York, USA)

    Objective: To estimate risk of Huntington’s disease (HD) over time in patients with reduced penetrance (RP) alleles (36-39 CAG repeats) overall, by individual repeat length,…
  • MDS Virtual Congress 2021

    Gabapentin-induced severe myoclonus in a patient with impaired renal function

    M. Akkari, M. Messelmani, H. Derbali, M. Mansour, A. Riahi, I. Bedoui, J. Zaouali, R. Mrissa (Tunis, Tunisia)

    Objective: The aim of this study was to present myoclonus as a reversible side effect of gabapentin in order to bring this trend to clinician’s…
  • MDS Virtual Congress 2021

    Clinical variants of PSP: phenotypical convergence and its relationship with the brain glucose metabolism

    G. Martí-Andrés, D. Vállez-García, E. Prieto, L. van Bommel, S. Meles, R. Valentí, R. Kogan, V. Gurvits, M. Riverol, MR. Luquin, KL. Leenders, J. Arbizu (Pamplona, Spain)

    Objective: To evaluate the phenotypical convergence phenomena among a cohort of different PSP variants. We also aimed to evaluate the possible correlations of the regional…
  • MDS Virtual Congress 2021

    GALLIC ACID AMELIORATES THE NEUROBEHAVIOURAL DEFICITS INDUCED BY BISPHENOL A (BPA) IN WISTAR RATS

    K. Adigun, M. Ehinmowo, A. Adebiyi, O. Adebiyi (Ibadan, Nigeria)

    Objective: Bisphenol A (BPA) has been found to exert neurotoxic effects through its neuroendocrine disruption and generation of reactive oxygen species (ROS). It can also…
  • « Previous Page
  • 1
  • …
  • 71
  • 72
  • 73
  • 74
  • 75
  • …
  • 132
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • An atypical and interesting feature of Parkinson´s disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley